Non-contraceptive applications of the levonorgestrel intrauterine system
نویسندگان
چکیده
Intrauterine progestins have many important current and potential gynecologic applications. This article describes the evidence for use of intrauterine progestin for common gynecologic conditions beyond its important role in contraception. The pharmacology of and selection criteria for use of the levonorgestrel intrauterine device is discussed, and the evidence for use of intrauterine progestin delivery for menorrhagia, endometriosis management, uterine fibroids, adenomyosis and endometrial hyperplasia is reviewed.
منابع مشابه
Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
The levonorgestrel-releasing intrauterine system (LNG-IUS), originally designed for contraception, has since been applied to various gynecologic diseases. This article summarizes the current status of clinical applications of LNG-IUS to the treatment of gynecologic diseases such as heavy menstrual bleeding, endometriosis, leiomyoma, adenomyosis, endometrial hyperplasia, and early-stage endometr...
متن کاملReview of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system
The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a co...
متن کاملNon-contraceptive Effects of Intrauterine Contraceptive Devices
There is a need for long-acting birth control methods. Copper-bearing intrauterine contraceptive devices do not have systemic side effects and they are appropriate for parous women who have no excess menstrual flow or cramps at baseline and who have low risk for sexually transmitted infections. Levonorgestrel-releasing intrauterine systems release levonorgestrel directly into uterine cavity. Th...
متن کاملNon-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Levonorgestrel releasing-intrauterine systems (LNG-IUS) were originally developed as a method of contraception in the mid 1970s. The only LNG-IUS approved for general public use is the Mirena LNG-IUS, which releases 20 mcg of levonorgestrel per day directly in to the uterine cavity. However, new lower dose (10 and 14 mcg per day) and smaller sized LNG-IUS (MLS, FibroPlant-LNG) are currently und...
متن کاملAPPLICATION FOR INCLUSION OF LEVONORGESTREL - RELEASING INTRAUTERINE SYSTEM FOR CONTRACEPTION IN THE 14 th WHO MODEL LIST OF ESSENTIAL MEDICINES
Background Contraception is a truly valuable medical advance for women and society. There are different contraceptive methods, and the women's choice and acceptance of them is likely to be affected by the efficacy, acceptability, tolerability and availability of alternatives and the desire not to conceive. In the 1970s a new approach to the delivery of hormonal contraception was researched and ...
متن کامل